Minireviews
Copyright ©The Author(s) 2017.
World J Clin Oncol. Jun 10, 2017; 8(3): 241-248
Published online Jun 10, 2017. doi: 10.5306/wjco.v8.i3.241
Table 3 Fertility Preservation options for reproductive age women with breast cancer
Fertility preservation optionCurrent statusAdvantagesDisadvantages
Embryo CryopreservationEstablishedHighest cumulative pregnancy ratesRequires about two weeks delay in the initiation of cancer treatment
Requires hormonal stimulation for oocyte retrieval
Requires in vitro fertilization with male partner or donor sperm
Oocyte CryopreservationEstablishedNo need for male partner or sperm donorRequires about two weeks delay in the initiation of cancer treatment
Requires hormonal stimulation for oocyte retrieval
Ovarian Tissue Cryopreservation and TransplantationCurrently experimental, may change as success rates are risingNo need for hormonal stimulationRequires outpatient laparoscopic surgery for ovarian tissue harvesting and subsequent transplantation
No need to significantly delay in the initiation of chemotherapy
No need for male partner or sperm donor